This is a patient who underwent viral hepatitis testing. Testing for viral hepatitis was denied by the plan as no identifiable risk factors for viral hepatitis were provided in the medical record. The patient's provider wrote a letter on behalf of the patient stating that testing was required as the patient was at risk due to sexual transmission. The healthplan's determination is overturned. Testing for hepatitis B virus (HBV) is indicated for: Those with signs and symptoms of acute or chronic hepatitis; asymptomatic patients who are at high risk for having been exposed to hepatitis B virus (HBV) or are at risk for severe adverse outcomes from undiagnosed infection. The majority of patients diagnosed with hepatitis C virus (HCV) infection have some identifiable risk factor that increases the likelihood of exposure to the virus. In the 1998 to 2002 National Health and Nutrition Examination Survey any history of injection drug use, a history of blood transfusion before 1992, or the presence of an abnormal serum alanine aminotransferase (ALT) level identified 85 percent of hepatitis C virus (HCV) RNA positive participants aged 20 to 59 years. The Centers for Disease Control and Prevention (CDC) now recommends all adults be screened for Hepatitis C. Hepatitis C is rarely transmitted sexually, however, the men who have sex with men (MSM) subgroup (the patient apparently belongs to this group ) are at higher risk and should undergo routine testing. It is appropriate to perform viral screening for hepatitis B and C.